National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

SB-AS02B adjuvant
A proprietary oil-in-water emulsion specifically designed for combining protein preparations used in vaccines. SB-AS02B adjuvant contains monophosphoryl lipid A and QS21, a saponin extracted from the South American tree Quillaja saponaria Molina. This agent may be used for formulating cancer-specific vaccine preparations such as those containing MAGE-3 melanoma protein. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:SB AS02B



Previous:sargramostim plasmid DNA melanoma vaccine adjuvant, sargramostim plasmid DNA pancreatic tumor cell vaccine, satraplatin, Satric, SB-743921
Next:SB-AS15 adjuvant, Sclerosol Intrapleural Aerosol, Se-methyl-seleno-L-cysteine, sedoxantrone trihydrochloride, selective androgen receptor modulator GTx-024

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov